Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells

被引:0
作者
Song, X [1 ]
Perkins, S [1 ]
Jortner, BS [1 ]
Ehrich, M [1 ]
机构
[1] VIRGINIA POLYTECH INST & STATE UNIV,VIRGINIA MARYLAND REG COLL VET MED,LAB NEUROTOXIC STUDIES,BLACKSBURG,VA 24061
关键词
MPTP; MPP+; SH-SY5Y human neuroblastoma cells; in vitro studies;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Morphological and metabolic endpoints were used to evaluate MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) toxicity to SH-SY5Y, human neuroblastoma cells. After 8 hours of exposure, MPTP was found to affect cell viability only at a very high concentration (3x10(-3) M) but its metabolite MPP+ could decrease viability at 10(-4) M. MPTP, via its metabolite MPP+, inhibited NADH dehydrogenase activity when concentrations exceeded 10(-4) M (for MPP+ 10(-5) M). The K-j, were 2.4 x 10(-3) M and 3 x 10(-4) M for MPTP and MPP, respectively. MPTP at concentrations greater than 10(-4) M altered cell morphology as early as one hour after exposure. These changes included formation of cell surface blebs and attenuated neurites. After 8 hours at 10(-3) M and 24 hrs at 10(-4) M, MPTP caused ultrastructural changes of mitochondria with increased electron-density of the matrix and disorganization of cristae, as well as abnormal aggregation of filamentous material of the cytoskeleton. changes of stucture and function took place at concentrations lower than those needed to affect cell viability, they may play a role in MPTP neurotoxicity in SH-SY5Y cell culture. (C) 1997 Inter Press, Inc.
引用
收藏
页码:341 / 353
页数:13
相关论文
共 56 条
[1]   MUSCARINIC RECEPTORS IN HUMAN SH-SY5Y NEUROBLASTOMA CELL-LINE - REGULATION BY PHORBOL ESTER AND RETINOIC ACID-INDUCED DIFFERENTIATION [J].
ADEM, A ;
MATTSSON, MEK ;
NORDBERG, A ;
PAHLMAN, S .
DEVELOPMENTAL BRAIN RESEARCH, 1987, 33 (02) :235-242
[2]  
BIEDLER JL, 1973, CANCER RES, V33, P2643
[3]  
BIEDLER JL, 1978, CANCER RES, V38, P3751
[4]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[5]  
CASTIGLIONI ET, 1986, TOXICOLOGY, V42, P303
[6]  
CASTIGLIONI ET, 1982, BIOCHEM PHARMACOL, V31, P181
[7]  
CASTIGLIONI ET, 1980, IN VITRO, V16, P591
[8]  
CHAN P, 1992, ANN NY ACAD SCI, V48, P306
[9]  
CHIUEH CC, 1984, EUR J PHARMACOL, V100, P189, DOI 10.1016/0014-2999(84)90221-8
[10]  
DENTON T, J NEUROCHEM, V49, P293